The recent recall of some pediatric medications, Tylenol, Motrin, Benadryl and Zyrtec, manufactured by Johnson & Johnson, prompted a Congressional investigation. A unit of Johnson & Johnson, McNeil Consumer Healthcare, is the company that actually manufacturers these over-the-counter drugs. The company is being scrutinized by the Food and Drug Administration for violations in the manufacturing of a number of drugs.
Due to Johnson & Johnson’s handling of the situation, the company has been cast in a very negative light with Mr. Edolphus Towns, the chairman of the House Oversight Committee and Government Reform. He says that they have been subjected to tactics that have delayed the process and also given some misinformation. Johnson & Johnson has denied this accusation.
A spokeswoman for McNeil said that the executives of the company have cooperated and about 20,000 pages of documents have been submitted.
Mr. Towns has been troubled by the discrepancies in Johnson & Johnson’s accounts of the statistics. They claim that the recall only involved 6 million bottles of pediatric medications while at the same time the company had informed the Food and Drug Administration that it involved more than 136 million bottles.
Ms. Jacobs explained that the 6 million bottles represented the bottles on the shelves of the stores at the time of the recall but that there was an estimated 136 million bottles which had already been purchased and was in the hands of the consumer.
After McNeil announced a voluntary recall of some of their pediatric medications, the House committee opened its investigation in early May. The recall was made due to the products containing metal particles with too much or too little of active and inactive ingredients which did not meet FDA standards. McNeil claims to have initiated additional safety programs in their plant.
An official recall was initiated when it was discovered that private contractors had been hired to purchase defective Motrin products from stores called “The Motrin Project.” One of McNeil’s executives, during a sworn statement, said that the “phantom recall” incident was limited and transparent. Later evidence suggested it was more like a covert operation in that McNeil had hired one contractor in 2009 to visit 5,000 stores for a whopping fee of $487,500. A document from another contractor instructed employees to simply “act like a regular customer” and not to mention anything about a recall. Ms. Jacobs claims that McNeil was unaware of this endeavor.
Mr. Towns cited further problems with McNeil. Peter Luther, the president of McNeil, told investigators that the Fort Washington Plant did not make products for other companies. This was proven wrong when Blacksmith Brands initiated its own voluntary recall of PediaCare. Ms. Jacobs stated that the plant had been sold and the Fort Washington Plant was temporarily producing these drugs during a time of transition to Blacksmith.
If you or a loved one has experienced serious side effects or health complications with a Johnson & Johnson product, contact Newsome Law Firm and fill out a case evaluation form today. Our team of attorneys has experience specific to complications associated with hazardous medication. Not only can they give you the legal guidance you need, they can help you get the compensation you deserve.